跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
黃 芝瑋
副研究員
,
醫學科技學院
https://orcid.org/0000-0002-2551-6199
電子郵件
gracehuang
tmu.edu
tw
h-index
635
引文
16
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2014
2025
每年研究成果
概覽
指紋
網路
專案
(9)
研究成果
(59)
資料集
(1)
類似的個人檔案
(9)
指紋
查看啟用 Chih-Wei Huang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Cancer Risk
88%
Malignant Neoplasm
69%
Odds Ratio
55%
Proton-Pump Inhibitor
53%
Empathy
53%
Case-Control Study
45%
Logistic Regression Analysis
40%
Electronic Health Record
40%
Patient Care
38%
Computerized Physician Order Entry
37%
Randomized Controlled Trial
37%
Clinical Research
36%
Physician
35%
Chronic Kidney Disease
35%
Female Genital Tract Cancer
35%
Breast Cancer
29%
Health Care
23%
Maturity Onset Diabetes of the Young
23%
Antidiabetic Agent
23%
Cervical Cancer
23%
Medicine
22%
Stomach Cancer
20%
Drug Use
20%
Patient Satisfaction
20%
Cardiovascular Disease
19%
Drug Therapy
19%
Ovarian Cancer
19%
Hepatocellular Carcinoma
17%
Patient Safety
17%
COVID-19
17%
Cohort Analysis
17%
Meta-Analysis
17%
Disease Association
17%
Arteriovenous Fistula
17%
Renin Angiotensin Aldosterone System
17%
Hemodialysis
17%
Critical Appraisal
17%
Maturation
17%
Benzodiazepine
17%
Community-Acquired Pneumonia
17%
Gene Expression Profiling
17%
Gout
17%
Blood Pressure
17%
Internal Medicine
17%
Dermatosis
17%
Checklist
17%
Occupation (Patient Social Context)
17%
4 Iodo 2,5 Dimethoxyamphetamine
17%
Traditional Chinese Medicine
17%
Digital Health
17%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Proton Pump Inhibitor
53%
Case-Control Study
53%
Breast Cancer
50%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
50%
Clinical Research
46%
Statin (Protein)
44%
Cohort Study
41%
Benzodiazepine
40%
Traditional Chinese Medicine
35%
Angiotensin
35%
Chronic Kidney Failure
35%
Female Genital Tract Cancer
35%
Observational Study
30%
Disease
29%
Comorbidity
27%
Uterine Cervix Cancer
26%
Cancer Registry
25%
Stomach Cancer
22%
Lung Cancer
20%
Angiotensin Receptor Antagonist
20%
Acetylsalicylic Acid
20%
Metformin
20%
Ovary Cancer
19%
Endometrium Cancer
18%
Dipeptidyl Carboxypeptidase Inhibitor
17%
Liver Cell Carcinoma
17%
Low Density Lipoprotein
17%
Major Adverse Cardiac Event
17%
Gout
17%
Thorax Pain
17%
Community Acquired Pneumonia
17%
Omega 6 Fatty Acid
17%
High Density Lipoprotein
17%
Lipoprotein
17%
Health Status
17%
Intubation
17%
Infection
17%
Aldosterone
17%
Hemodialysis
17%
Parkinson's Disease
17%
Arteriovenous Fistula
17%
Epidermal Growth Factor Receptor
17%
Vaccination Policy
17%
Renin
17%
Sodium Glucose Cotransporter 2 Inhibitor
17%
Cardiovascular Disease
17%
Antidiabetic Agent
17%
Kidney Disease
17%
Selective Serotonin Reuptake Inhibitor
17%
Nursing and Health Professions
Hemodialysis
35%
Patient Care
31%
Electronic Health Record
26%
Odds Ratio
24%
Confidence Interval
23%
Receiver Operating Characteristic
22%
Breast Cancer
21%
Artificial Intelligence
20%
Meta Analysis
17%
Physician
17%
Non Melanoma Skin Cancer
17%
Cohort Analysis
17%
Public Health Informatics
17%
Statin (Protein)
17%
Liver Cell Carcinoma
17%
Health Care Delivery
17%
Empathy
17%
Healthcare System
17%
Hospital
17%
Pilot Study
17%
Case-Control Study
17%
Drug Use
17%
Gout
17%
Pressure Injury
17%
Malignant Neoplasm
17%
Hospital Service
17%
Chronic Kidney Failure
17%
Image Subtraction
17%
Arteriovenous Fistula
17%
Health Literacy
17%
Bibliometrics
17%
Sodium Glucose Cotransporter 2 Inhibitor
17%
Drug Therapy
15%
Area under the Curve
14%
Disease
14%
Robotics
14%
Sensitivity and Specificity
10%
Infection
10%
Health Care Personnel
10%
Doctor Patient Relation
10%
Laxative
9%
Statins therapy
8%
Comorbidity
8%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
5%
Health Status
5%
Resource Allocation
5%
Vaccination Policy
5%
Neutrophil Count
5%
Predictive Value
5%
Platelet Count
5%
